Rapid Micro Biosystems, Inc. (RPID)

CIK 0001380106 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-07) · 99.1
Q1-2026 8-K (2026-05-13) · 99.1
Latest FY-2025 8-K (2026-03-12) · 99.1 · 99.2  |  8-K (2026-01-13) · 99.1
Q3-2025 8-K (2025-11-07) · 99.1
Q2-2025 8-K (2025-08-12) · 99.1 · 99.2
Q1-2025 8-K (2025-05-09) · 99.1
FY-2024 8-K (2025-02-28) · 99.1  |  8-K (2025-01-14) · 99.1
Q3-2024 8-K (2024-11-01) · 99.1
Q2-2024 8-K (2024-08-02) · 99.1
Q1-2024 8-K (2024-05-03) · 99.1
FY-2023 8-K (2024-03-01) · 99.1  |  8-K (2024-01-10) · 99.1
Q3-2023 8-K (2023-11-03) · 99.1
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Accrued Expenses and Other Current Liabilities
Benefit Plans
Commitments and Contingencies
Common Stock and Common Stock Warrants
Cybersecurity Risk Management and Strategy Disclosure
—
Fair Value of Financial Assets and Liabilities
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Inventory
Inventory, Net
Investments
Leases
Nature of The Business and Basis of Presentation
Net Loss Per Share
Notes Payable, Net
Pay Vs Performance Disclosure
Prepaid Expenses and Other Current Assets
Property and Equipment, Net
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies